Immunohistochemical differences between hyaluronan- and non-hyaluronan-producing malignant mesothelioma

European Respiratory Journal

Volumn 10, Issue 2, 1997, Pages 404-408

  Thylen A ^a   Levin Jacobsen, A M ^a   Hjerpe, A ^b   Martensson, G ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

hyaluronan; immunohistochemistry; mesothelioma; pleural fluid

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CYTOKERATIN ANTIGEN; EPITHELIAL MEMBRANE ANTIGEN; HYALURONIC ACID; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; VIMENTIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MALIGNANT MESOTHELIOMA; PLEURA FLUID; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031052082     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10020404     Document Type: Article

References (21)

1. McDonald AD, McDonald CJ. Epidemiology of malignant mesothelioma. In: Antman K, Aisner J. Asbestos-related Malignancy. Orlando, Harcourt Brace Jovanovich 1987; pp. 31-55.
2. Martensson G. Diagnosing malignant pleural mesothelioma. Eur Respir J 1990; 3: 985-986.
3. Wirth PR, Legier J, Wright GL. Immunohistochemical evaluation of seven monoclonal antibodies for differentiation of pleural mesothelioma from lung adenocarcinoma. Cancer 1991; 67: 655-662.
4. Al-Saffar N, Hasleton PS. Vimentin, carcinoembryonic antigen and keratin in the diagnosis of mesothelioma, adenocarcinoma and reactive pleural lesions. Eur Respir J 1990; 3: 997-1001.
5. Dejmek A, Hjerpe A. Carcinoembryonic antigen-like reactivity in malignant mesothelioma. Cancer 1994; 73: 464-469.
6. Dejmek A, Hjerpe A. Immunohistochemical reactivity in mesothelioma and adenocarcinoma: a stepwise logistic regression analysis. APMIS 1994; 102: 255-264.
7. Bolen JW, Hammar SP, McNutt MA. Reactive and neoplastic serosal tissue: a light-microscopic, ultrastructural, and immunocytochemical study. Am J Surg Pathol 1986; 10(1): 34-47.
8. Johansson L, Lindén CJ. Review of malignant mesotheliomas in Lund, Sweden, 1980-1990: histopathological and immunohistochemical features - preliminary results. Eur Respir Rev 1993; (11): 61-63.
9. Blobel GA, Moll R, Franke WW, Kayser KW, Gould VE. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol 1985; 121: 235-247.
10. Pfaltz M, Odermatt B, Christen B, Rüttner JR. Immunohistochemistry in the diagnosis of malignant mesothelioma. Virchows Arch A 1987; 411: 387-393.
11. Meyer K, Chaffee E. Hyaluronic acid in pleural fluid associated with malignant tumour involving pleura and peritoneum. Proc Soc Exp Biol Med 1939; 42: 797-800.
12. Nurminen M, Dejmek A, Martensson G, Thylén A, Hjerpe A. Clinical utility of liquid-chromatographic analysis of effusions for hyaluronate content. Clin Chem 1994; 40(5): 777-780.
13. Hjerpe A. Liquid-chromatographic determination of hyaluronic acid in pleural and ascitic fluids. Clin Chem 1986; 32: 952-956.
14. Chailleux E, Dabouis G, Pioche D, De Lajartre M, Rembeaux A, Germaud P. Prognostic factors in diffuse malignant mesothelioma: a study of 167 patients. Chest 1988; 93: 159-162.
15. Antman K, Shemin R, Ryan L, et al. Prognostic variables in a registry of 180 patients. J Clin Oncol 1988; 6: 147-153.
16. Boutin C, Rey F, Gouvernet J, Viallat JR, Astoul Ph, Ledoray V. Thorascopy in pleural malignant mesothelioma: a prospective study of 188 consecutive patients. Part 2. Prognosis and staging. Cancer 1993; 72: 394-404.
17. Corson JM. Pathology of malignant mesothelioma. In: Antman K, Aisner J, ed. Asbestos-related malignancy. Orlando, Harcourt Brace Jovanovich 1987; pp. 179-199.
18. Martensson G, Thylén A, Lindqvist U, Hjerpe A. The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods. Cancer 1994; 73: 1406-1410.
19. Prehm P. Hyaluronate is synthesized at plasma membranes. Biochem J 1984; 220: 597-600.
20. Leong AS-Y, Parkinson R, Milios J. "Thick" cell membranes revealed by immunocytochemical staining: a clue to the diagnosis of mesothelioma. Diagn Cytopathol 1990; 6: 9-13.
21. Van der Kwast TH, Versnel MA, Delahaye M, De Jong A, Zondervan PE, Hoogsteden H. Expression of epithelial membrane antigen on malignant mesothelioma cells: an immunocytochemical and immunoelectron microscopic study. Acta Cytol 1988; 32(2): 169-174.